Zhou, J., Zhuang, H., Sheng, Q., Qiu, Z., & Chen, Y. (2026). Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism. Pharmaceutics, 18(5), 547. https://doi.org/10.3390/pharmaceutics18050547
Chicago Style (17th ed.) CitationZhou, Jinhua, Hongda Zhuang, Qinghua Sheng, Zhitao Qiu, and Yong Chen. "Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism." Pharmaceutics 18, no. 5 (2026): 547. https://doi.org/10.3390/pharmaceutics18050547.
MLA (9th ed.) CitationZhou, Jinhua, et al. "Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism." Pharmaceutics, vol. 18, no. 5, 2026, p. 547, https://doi.org/10.3390/pharmaceutics18050547.